The interaction of nemorubicin metabolite PNU-159682 with DNA fragments d(CGTACG)2, d(CGATCG)2 and d(CGCGCG)2 shows a strong but reversible binding to G:C base pairs
Authors:
- Stefania MazziniSMStefania Mazzini
- Leonardo ScaglioniLSLeonardo Scaglioni
- Rosanna MondelliRMRosanna Mondelli
- Michele CarusoMCMichele Caruso
- Federico Riccardi SirtoriFSFederico Riccardi Sirtori
- 1 December 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (24) , 6979-6988
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Down-regulation of the Nucleotide Excision Repair gene XPG as a new mechanism of drug resistance in human and murine cancer cellsMolecular Cancer, 2010
- In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomesBiochemical Pharmacology, 2008
- Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver MicrosomesClinical Cancer Research, 2005
- Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinomaAnti-Cancer Drugs, 2004
- Structure and dynamics of intercalation complexes of anthracyclines with d(CGATCG)2 and d(CGTACG)2. 2D-1H and 31P NMR investigationsJournal of the Chemical Society, Perkin Transactions 2, 1998
- Doxoform and Daunoform: Anthracycline−Formaldehyde Conjugates Toxic to Resistant Tumor CellsJournal of Medicinal Chemistry, 1997
- 31P NMR studies on the interaction of morpholinyl anthracyclines and related compounds with d(CGTACG)2. Thermodynamic and kinetic parametersApplied Magnetic Resonance, 1994
- Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linkerBritish Journal of Cancer, 1994
- Formaldehyde crosslinks daunorubicin and DNA efficiently: HPLC and x-ray diffraction studiesBiochemistry, 1991
- Novel anthracycline analogsCancer Treatment Reviews, 1990